Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • Log out
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • Log out
  • My Cart

Search

  • Advanced search
Antimicrobial Agents and Chemotherapy
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
LETTERS TO THE EDITOR

First Isolation of blaVIM-2 in Klebsiella oxytoca Clinical Isolates from Portugal

T. Conceição, A. Brízio, A. Duarte, R. Barros
T. Conceição
Laboratório de Microbiologia Faculty of Pharmacy Av. Forças Armadas 1649-019 Lisbon, Portugal
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A. Brízio
Laboratório de Microbiologia Faculty of Pharmacy Av. Forças Armadas 1649-019 Lisbon, Portugal
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A. Duarte
Laboratório de Microbiologia Faculty of Pharmacy Av. Forças Armadas 1649-019 Lisbon, Portugal
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: aduarte@ff.ul.pt
R. Barros
Hospital Dona EstefÂnia Lisbon, Portugal
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/AAC.49.1.476.2005
  • Article
  • Info & Metrics
  • PDF
Loading

VIM-type carbapenemases were originally detected in Europe (2, 4, 7) and have been essentially found in Pseudomonas aeruginosa, as well as in Enterobacteriaceae (2, 6, 8). The blaVIM genes are often carried by mobile gene cassettes inserted into class 1 integrons (7, 11). The Klebsiella genus is responsible for the most frequent human nosocomial infections of the respiratory and urinary tracts. Four Klebsiella oxytoca clinical isolates were recovered by blood culture from neonatal patients at a pediatric hospital. The clinical isolates showed resistance to amoxicillin and ticarcillin, which was restored by clavulanate, aminoglycosides, and fluoroquinolones, and intermediate susceptibility to imipenem (MIC, 4 μg/ml) and broad-spectrum cephalosporins and aztreonam (MICs, 8 and 16 μg/ml) and were susceptible to meropenem (MIC, 0.075 μg/ml). A deformation of ellipses between the two gradient sections with E-test MBL (metallo-β-lactamase) strips was indicative of MBL production (10).

Plasmid DNA was prepared by the alkaline lysis method (9), and the same 50-kb plasmid was detected in all of the isolates. Conjugation experiments were attempted with rifampin-resistant strain Escherichia coli C600 in liquid and solid media. E. coli DH10B was used as the bacterial host in electroporation experiments. No resistance phenotype transfer was observed in conjugation or transformation experiments.

M13 PCR fingerprinting, used as a typing method, was performed by using the core region of bacteriophage M13 as the primer (3). The four isolates have the same M13 profile.

Since several β-lactamase genes are part of gene cassettes included in class 1 integrons, PCR was performed for class 1 integrons with 5′-CS and 3′-CS primers (5) on plasmid DNA from K. oxytoca 17FFUL purified by a QIAGEN Plasmid Midi Kit, yielding an amplicon with a size of 3,500 bp. Consecutive PCR amplifications with specific primers for MBL and aminoglycoside acetyltransferase genes were performed. Analysis of sequence data revealed the presence of four gene cassettes in the class 1 integron. The first cassette contained the blaVIM-2 gene, coding for an MBL. The second and the third cassettes contained genes coding for 6′-N-aminoglycoside acetyltransferase (aacA4) and an aminoglycoside adenylyltransferase (aadA1), respectively. The last gene cassette contains a blaOXA-2 gene coding for an oxacillinase.

As in P. aeruginosa COL-1 (7), the blaVIM-2 gene was found to be carried on a plasmid-borne integron. However, the VIM-2-encoding plasmids and the structure of the blaVIM-2 gene cassette were different in the two bacteria. Key signatures of class 1 integrons were identified, such as a 5′-CS attI1 recombination site, a core site (GTTATGC), and an inverse core site (GCATAAC). The 59-base element was 72 bp long as the 59-base element of the blaVIM-2 gene cassette in COL-1 but differed by three nucleotides, showing 95.8% homology.

A chromosomal blaVIM-2 gene in a P. aeruginosa clinical isolate was already detected in Portugal (1), and the detection of a plasmid-borne blaVIM-2 gene in K. oxytoca demonstrates that the problem of MBL-producing pathogens no longer involves gram-negative nonfermenters alone but also involves enterobacteria.

This study found that a clonal VIM-2 spread occurred in the pediatric ward during the study.

  • American Society for Microbiology

REFERENCES

  1. ↵
    Cardoso, O., R. Leitão, A. Figueiredo, J. Sousa, A. Duarte, and L. Peixe. 2002. Metallo-β-lactamase VIM-2 in clinical isolates of Pseudomonas aeruginosa from Portugal. Microb. Drug Resist. 8(2):93-97.
    OpenUrlCrossRefPubMedWeb of Science
  2. ↵
    Giakkoupi, P., A. Xanthaki, M. Kanelopoulou, A. Vlahaki, V. Miriagou, S. Kontou, E. Papafraggas, H. Malamou-Lada, L. S. Tzouvelekis, N. J. Legakis, and A. C. Vatopoulos. 2003. VIM-1 metallo-β-lactamase-producing Klebsiella pneumoniae strains in Greek hospitals. J. Clin. Microbiol. 41:3893-3896.
    OpenUrlAbstract/FREE Full Text
  3. ↵
    Grundmann, H. J., K. J. Towner, L. Dijkshoorn, P. Gerner-Smidt, M. Maher, H. Seifert, and M. Vaneechoutte. 1997. Multicenter study using standardized protocols and reagents for evaluation of reproducibility of PCR-based fingerprinting of Acinetobacter spp. J. Clin. Microbiol. 35:3071-3077.
    OpenUrlAbstract/FREE Full Text
  4. ↵
    Lauretti, L., M. L. Riccio, A. Mazzariol, G. Cornaglia, G. Amicosante, R. Fontana, and G. M. Rossolini. 1999. Cloning and characterization of blaVIM, a new integron-borne metallo-β-lactamase gene from a Pseudomonas aeruginosa clinical isolate. Antimicrob. Agents Chemother. 43:1584-1590.
    OpenUrlAbstract/FREE Full Text
  5. ↵
    Lévesque, C., L. Piché, C. Larose, and P. H. Roy. 1995. PCR mapping of integrons reveals several novel combinations of resistance genes. Antimicrob. Agents Chemother. 39:185-191.
    OpenUrlAbstract/FREE Full Text
  6. ↵
    Nordmann, P., and L. Poirel. 2002. Emerging carbapenemases in gram negative aerobes. Clin. Microbiol. Infect. 8:321-331.
    OpenUrlCrossRefPubMedWeb of Science
  7. ↵
    Poirel, L., T. Naas, D. Nicolas, L. Collet, S. Bellais, J.-D. Cavallo, and P. Nordmann. 2000. Characterization of VIM-2, a carbapenem-hydrolyzing metallo-β-lactamase and its plasmid- and integron-borne gene from a Pseudomonas aeruginosa clinical isolate in France. Antimicrob. Agents Chemother. 44:891-897.
    OpenUrlAbstract/FREE Full Text
  8. ↵
    Rossolini, G. M., M. L. Riccio, G. Cornaglia, L. Pagani, C. Lagatolla, L. Selan, and R. Fontana. 2000. Carbapenem-resistant Pseudomonas aeruginosa with acquired blaVIM metallo-β-lactamase determinants, Italy. Emerg. Infect. Dis. 6:312-313.
    OpenUrlCrossRefPubMed
  9. ↵
    Sambrook, J., and D. W. Russell. 2001. Molecular cloning: a laboratory manual, 3rd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
  10. ↵
    Walsh, T. R., A. Bolmström, A. Qwärnström, and A. Gales. 2002. Evaluation of a new Etest for detecting metallo-β-lactamases in routine clinical testing. J. Clin. Microbiol. 40:2755-2759.
    OpenUrlAbstract/FREE Full Text
  11. ↵
    Yatsuyanagi, J., S. Saito, S. Harata, N. Suzuki, Y. Ito, K. Amano, and K. Enomoto. 2004. Class 1 integron containing metallo-β-lactamase gene blaVIM-2 in Pseudomonas aeruginosa clinical strains isolated in Japan. Antimicrob. Agents Chemother. 48:626-628.
    OpenUrlAbstract/FREE Full Text
PreviousNext
Back to top
Download PDF
Citation Tools
First Isolation of blaVIM-2 in Klebsiella oxytoca Clinical Isolates from Portugal
T. Conceição, A. Brízio, A. Duarte, R. Barros
Antimicrobial Agents and Chemotherapy Dec 2004, 49 (1) 476; DOI: 10.1128/AAC.49.1.476.2005

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Antimicrobial Agents and Chemotherapy article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
First Isolation of blaVIM-2 in Klebsiella oxytoca Clinical Isolates from Portugal
(Your Name) has forwarded a page to you from Antimicrobial Agents and Chemotherapy
(Your Name) thought you would be interested in this article in Antimicrobial Agents and Chemotherapy.
Share
First Isolation of blaVIM-2 in Klebsiella oxytoca Clinical Isolates from Portugal
T. Conceição, A. Brízio, A. Duarte, R. Barros
Antimicrobial Agents and Chemotherapy Dec 2004, 49 (1) 476; DOI: 10.1128/AAC.49.1.476.2005
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • REFERENCES
  • Info & Metrics
  • PDF

Related Articles

Cited By...

About

  • About AAC
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #AACJournal

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

Copyright © 2019 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0066-4804; Online ISSN: 1098-6596